Digital therapeutics are software-based interventions designed to prevent, manage, or treat a medical condition. Unlike general wellness apps, a DTx product is built around a therapeutic claim, so its effectiveness depends on clinical evidence, controlled updates, and the intended medical use approved in a given jurisdiction. That regulatory context matters because the same app can be treated as a medical device in one place and as a consumer product in another.
From a cybersecurity perspective, DTx systems are high-value targets because they may handle sensitive health data and influence patient care. Attackers can try to tamper with treatment logic, steal personal information, abuse update channels, or exploit weak access control in companion apps and cloud services. Defenders focus on secure development, code signing, audit logging, least privilege, vulnerability management, and rigorous change control so the therapy remains trustworthy after deployment.